Improve-it trial wiki
WitrynaIMPROVE-IT(Improved Reduction of Outcomes: Vytorin Efficacy International Trial [进一步降低终点事件:葆至能疗效国际试验])是一项在急性冠脉综合征的高危患者中确 … Witryna17 lis 2014 · The trial was not designed to test treatment to specific LDL-cholesterol targets. It was designed to test a single drug strategy (simvastatin) versus a …
Improve-it trial wiki
Did you know?
Witryna14 lis 2024 · Objective To assess the three year clinical outcomes and cost effectiveness of a strategy of endovascular repair (if aortic morphology is suitable, open repair if not) versus open repair for patients with suspected ruptured abdominal aortic aneurysm. Design Randomised controlled trial. Setting 30 vascular centres (29 in UK, one in … Witryna15 mar 2015 · Arial MS Pゴシック Tahoma Monotype Sorts Lucida Grande Calibri Times New Roman Cambria improve-it_template_12nov2014 Microsoft Excel Chart Reduction in Total (First and Recurrent) Cardiovascular Events with Ezetimibe/Simvastatin compared with Simvastatin Alone post ACS in the IMPROVE-IT Trial Background: …
WitrynaIMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin) therapy … WitrynaExpert opinion: The results from IMPROVE-IT revalidated the concept that low-density lipoprotein cholesterol (LDL-C) levels are a clinically relevant treatment goal. This trial also suggested that further decrease of LDL-C levels (53 vs. 70 mg/dl; 1.4 vs. 1.8 mmol/l) was more beneficial in lowering CV events.
Witryna20 wrz 2005 · Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus … Witryna21 lis 2014 · Nissen believes IMPROVE-IT is a positive trial, and despite flaws, it is a statistically valid result. He pointed out that the treatment effect was observed in a very high-risk patient population ...
Witryna10 gru 2014 · The IMPROVE-IT Trial The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) is a randomized control study established to examine the clinical benefit and safety of Vytorin (ezetimibe/simvastatin) versus simvastatin alone in high-risk patients with post acute coronary syndrome. Additional …
Witryna10 lis 2024 · Ongoing trials of moderate-to-high doses of pure EPA ethyl ester will provide further information on the effects of these agents. 10,36 These trials include the Randomized Trial for... clicker heroes import code makerWitryna14 gru 2024 · Lack of formal neurocognitive assessments prevents better characterization of this possible side effect of alirocumab therapy; Funding. Study funded by Sanofi and Regeneron Pharmaceuticals, the makers of Praluent (the brand name of alirocumab) Sponsors designed the trial protocol and were involved in data collection, … clicker heroes import cheatWitryna12 lut 2024 · IMPROVE-IT, a contemporary, large, and well-designed trial, unequivocally demonstrated reduction in CV outcomes with ezetimibe when added to statin therapy. … clicker heroes import hackhttp://www.wikijournalclub.org/wiki/IMPROVE-IT clicker heroes import code hackWitrynaThe IMPROVE-IT trial is a landmark clinical trial that demonstrated the incremental clinical benefit of adding a non-statin (ezetimibe) to a statin (simvasta... clicker heroes import code opWitrynaThe Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) evaluated the effect of ezetimibe combined with simvastatin, as compared with that of … bmw of akron fireWitryna31 maj 2024 · In summary, the DANAMI-3 PRIMULTI trial provides further evidence that treatment of non-infarct related arteries discovered during STEMI is beneficial, and suggests that the use of FFR-guidance remains beneficial even in the recent ACS setting. The subsequent Compare-Acute trial showed similar findings. On the strength of … clicker heroes import file